NBIS vs PG: Which Is the Better Buy?
Side-by-side comparison of Nebius Group N.V. and The Procter & Gamble Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
Nebius Group N.V. · Technology
$217.99
+45.0% upside to fair value
Med Conviction
Grade B
VS
The Procter & Gamble Company · Consumer Defensive
$147.04
+14.4% upside to fair value
Med Conviction
Grade B+
High Quality
QuantHub Verdict
NBIS has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
NBIS |
PG |
| Current Price |
$217.99 |
$147.04 |
| Fair Value Estimate |
$316.09 |
$168.19 |
| Upside to Fair Value |
+45.0%
|
+14.4%
|
| Market Cap |
$52.3B |
$349.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
56.8x
|
17.6x
|
| Price / Sales |
38.6x
|
4.0x
|
| Price / FCF |
—
|
22.4x
|
| Revenue Growth YoY |
+454.0%
|
+1.5%
|
| Gross Margin |
58.6%
|
50.2%
|
| Operating Margin |
-49.3%
|
22.7%
|
| Return on Equity |
0.9%
|
29.8%
|
| Dividend Yield |
0% |
2.92% |
| FCF Yield |
—
|
4.47%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Nebius Group N.V. is an Amsterdam-based AI infrastructure company, formerly Yandex N.V., that builds end-to-end GPU cloud clusters, cloud platforms and developer tools for demanding AI workloads, alongside Toloka AI data solutions, TripleTen education and Avride autonomous driving. The business is growing explosively, with revenue up 454.0% year over year in the most recent quarter, and it has de…
Procter & Gamble is a global consumer-staples leader selling daily-use products across beauty, grooming, health care, fabric and home care, and baby, feminine and family care in about 180 countries. Business quality is high because its brands, consumer insight, R&D, marketing scale and global distribution underpin leading category positions, including over 60% in blades and razors and over 35% in…
Accumulation Zones
| Metric |
NBIS |
PG |
| Zone Low |
$237.07 |
$126.14 |
| Zone High |
$268.68 |
$142.96 |
| In Buy Zone? |
Yes
|
No
|